Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 23% ± 4% | |
astrocyte | 6 studies | 25% ± 9% | |
adipocyte | 5 studies | 31% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 7% | |
epithelial cell | 3 studies | 25% ± 7% | |
GABAergic neuron | 3 studies | 28% ± 4% | |
glutamatergic neuron | 3 studies | 30% ± 10% | |
microglial cell | 3 studies | 21% ± 3% | |
alveolar macrophage | 3 studies | 19% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 16% ± 0% | |
macrophage | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1378.05 | 459 / 459 | 100% | 55.97 | 1113 / 1118 |
ovary | 100% | 969.17 | 180 / 180 | 97% | 34.91 | 419 / 430 |
esophagus | 100% | 1155.19 | 1445 / 1445 | 97% | 29.43 | 178 / 183 |
uterus | 100% | 1249.89 | 170 / 170 | 97% | 29.56 | 445 / 459 |
thymus | 100% | 1026.10 | 653 / 653 | 96% | 22.63 | 580 / 605 |
lung | 100% | 1420.44 | 578 / 578 | 96% | 24.24 | 1107 / 1155 |
pancreas | 99% | 694.16 | 326 / 328 | 96% | 22.75 | 171 / 178 |
prostate | 100% | 900.64 | 245 / 245 | 94% | 16.94 | 470 / 502 |
brain | 99% | 559.98 | 2607 / 2642 | 94% | 16.11 | 666 / 705 |
kidney | 100% | 1151.67 | 89 / 89 | 89% | 24.38 | 804 / 901 |
stomach | 100% | 855.12 | 359 / 359 | 89% | 16.47 | 255 / 286 |
intestine | 100% | 1320.33 | 966 / 966 | 86% | 14.91 | 451 / 527 |
bladder | 100% | 999.14 | 21 / 21 | 84% | 20.53 | 424 / 504 |
liver | 100% | 700.64 | 226 / 226 | 77% | 11.27 | 314 / 406 |
skin | 100% | 1214.68 | 1809 / 1809 | 72% | 15.07 | 341 / 472 |
adrenal gland | 100% | 1055.86 | 258 / 258 | 71% | 10.54 | 163 / 230 |
adipose | 100% | 1370.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1610.22 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1183.20 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 587.34 | 797 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 39.46 | 44 / 45 |
heart | 97% | 523.58 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1316.38 | 898 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 19.81 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 23% | 2.01 | 18 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0034344 | Biological process | regulation of type III interferon production |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0045087 | Biological process | innate immune response |
GO_0002735 | Biological process | positive regulation of myeloid dendritic cell cytokine production |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0009615 | Biological process | response to virus |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0051607 | Biological process | defense response to virus |
GO_0060760 | Biological process | positive regulation of response to cytokine stimulus |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_0009597 | Biological process | detection of virus |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_0030334 | Biological process | regulation of cell migration |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0039529 | Biological process | RIG-I signaling pathway |
GO_0010467 | Biological process | gene expression |
GO_0071360 | Biological process | cellular response to exogenous dsRNA |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0032587 | Cellular component | ruffle membrane |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005923 | Cellular component | bicellular tight junction |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0038187 | Molecular function | pattern recognition receptor activity |
GO_0003727 | Molecular function | single-stranded RNA binding |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005525 | Molecular function | GTP binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | RIGI |
Protein name | Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) DDX58 protein RNA helicase (EC 3.6.4.13) RNA sensor RIG-I Alternative protein DDX58 |
Synonyms | DDX58 |
Description | FUNCTION: Innate immune receptor that senses cytoplasmic viral nucleic acids and activates a downstream signaling cascade leading to the production of type I interferons and pro-inflammatory cytokines . Forms a ribonucleoprotein complex with viral RNAs on which it homooligomerizes to form filaments . The homooligomerization allows the recruitment of RNF135 an E3 ubiquitin-protein ligase that activates and amplifies the RIG-I-mediated antiviral signaling in an RNA length-dependent manner through ubiquitination-dependent and -independent mechanisms . Upon activation, associates with mitochondria antiviral signaling protein (MAVS/IPS1) that activates the IKK-related kinases TBK1 and IKBKE which in turn phosphorylate the interferon regulatory factors IRF3 and IRF7, activating transcription of antiviral immunological genes including the IFN-alpha and IFN-beta interferons . Ligands include 5'-triphosphorylated ssRNAs and dsRNAs but also short dsRNAs (<1 kb in length) . In addition to the 5'-triphosphate moiety, blunt-end base pairing at the 5'-end of the RNA is very essential . Overhangs at the non-triphosphorylated end of the dsRNA RNA have no major impact on its activity . A 3'overhang at the 5'triphosphate end decreases and any 5'overhang at the 5' triphosphate end abolishes its activity . Detects both positive and negative strand RNA viruses including members of the families Paramyxoviridae: Human respiratory syncytial virus and measles virus (MeV), Rhabdoviridae: vesicular stomatitis virus (VSV), Orthomyxoviridae: influenza A and B virus, Flaviviridae: Japanese encephalitis virus (JEV), hepatitis C virus (HCV), dengue virus (DENV) and west Nile virus (WNV) . It also detects rotaviruses and reoviruses . Detects and binds to SARS-CoV-2 RNAs which is inhibited by m6A RNA modifications (Ref.69). Also involved in antiviral signaling in response to viruses containing a dsDNA genome such as Epstein-Barr virus (EBV) . Detects dsRNA produced from non-self dsDNA by RNA polymerase III, such as Epstein-Barr virus-encoded RNAs (EBERs). May play important roles in granulocyte production and differentiation, bacterial phagocytosis and in the regulation of cell migration. . |
Accessions | A0A7P0Z442 A0A7P0T9I8 A2A376 ENST00000379868.6 [O95786-2] ENST00000379883.3 [O95786-1] O95786 B3KWW1 ENST00000679665.1 ENST00000680733.1 A0A7P0Z425 ENST00000379868 Q3B797 ENST00000679859.1 L8E813 ENST00000679771.1 |